Across TCGA pan-cancer cohorts, MIR1296 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR1296 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR1296 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR1296 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LAML show a favorable association.
STAD, LUAD, and ACC are the cancer types where MIR1296 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.